Neu antigen-negative variants can be generated after neu-specific antibody therapy in neu transgenic mice.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000494:pharmacology*; D000918:Antibody Specificity; D002455:Cell Division / Q000276:immunology; D045744:Cell Line, Tumor; D005260:Female; D007116:Immunization, Passive / Q000379:methods*; D008325:Mammary Neoplasms, Experimental / Q000276:immunology* / Q000628:therapy*; D051379:Mice; D008822:Mice, Transgenic; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis / Q000276:immunology*
D000911:Antibodies, Monoclonal; D018719:Erb-b2 Receptor Tyrosine Kinases